gave | Thursday, March 25, 2021 – 10:11 | Last Updated: 25 03 2021 – 10:11
Zonguldak Bülent Ecevit University Faculty of Arts and Sciences Faculty of Chemistry Faculty Member Assoc. Dr. Zuhal Gerçek has developed a new active substance that prevents the coronavirus from multiplying in the body. Stating that the active substance he developed can be used in drugs given to patients with Covid-19, Assoc. Dr. The truth said, “When we take the virus into our body, the virus starts to increase its number immediately. This drug prevents the virus from replicating itself. Therefore, since the number of viruses is kept to a minimum, the person may not even show the symptoms of the disease,” he said.
Assoc. Dr. Zuhal Gerçek said that he thought the compounds synthesized in the study would be a hope against the Covid-19 epidemic that all humanity was dealing with. Assoc. Dr. Real, “For this purpose, we synthesized 7 new materials. We looked at their interactions with Covid-19 RNA and Sars Cov-2 RNA. The compounds we target were designed to prevent the reproduction of the virus in the fight against Covid. Our academicians from Tekirdağ University, who supported the study of their interactions, studied the RNA binding energies of the active compounds we synthesized with the currently used Covid drugs. has been proven to be, “he said.
‘THE PERSON MAY NOT SHOW SYMPTOMS OF THE DISEASE’
Stating that another feature of the compounds that emerged in the study is that their production synthesis is very easy, Assoc. Dr. Real stated that it was aimed to make the cost low and the efficiency as efficient as possible in this way. Stating that they have achieved this, Assoc. Dr. The truth spoke as follows:
“Thanks to the method we use, there is a lot of chance of derivatization. When we take the virus into our body, the virus starts to increase the number immediately. This drug prevents the virus from replicating itself. Therefore, since the number of viruses is kept to a minimum, the person may not even show the symptoms of the disease. We need a group to work with us to develop this study. We did the interaction of the synthesized molecules with the RNAs. We also simulated the interaction to prove that it remained stable in the enzyme. As a result of the simulation, it was proved that the molecule settled very nicely and remained stable here. “